Research graph
References from EQUITY-MS: evaluating the quality of investigation and treatment of multiple sclerosis using data from five specialist neurology centres in the UK—study protocol. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s1474-4422(18)30443-5
10.1016/s1474-4422(18)30443-5 · External reference
Unresolved reference
External reference
10.1097/wco.0000000000000094
10.1097/wco.0000000000000094 · External reference
10.1016/b978-0-444-52001-2.00010-8
10.1016/b978-0-444-52001-2.00010-8 · External reference
The basis for treatment in multiple sclerosis
10.1111/j.1600-0404.2006.00614.x · 2006 · External reference
10.1001/jama.2020.26858
10.1001/jama.2020.26858 · External reference
10.1111/ene.13819
10.1111/ene.13819 · External reference
10.1016/s1474-4422(15)00018-6
10.1016/s1474-4422(15)00018-6 · External reference
10.1212/nxi.0000000000200005
10.1212/nxi.0000000000200005 · External reference
Unresolved reference
External reference
10.1016/s1474-4422(20)30067-3
10.1016/s1474-4422(20)30067-3 · External reference
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis
10.1001/jamaneurol.2018.4905 · 2019 · External reference
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National Strategies
10.1001/jamaneurol.2021.2738 · 2021 · External reference
Unresolved reference
External reference
10.1038/s41582-022-00735-5
10.1038/s41582-022-00735-5 · External reference
Maternal education has significant influence on progression in multiple sclerosis
10.1016/j.msard.2021.103052 · 2021 · External reference
10.1136/jnnp-2024-333338
10.1136/jnnp-2024-333338 · External reference
Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients
10.1371/journal.pone.0191646 · 2018 · External reference
Socioeconomic status and disability progression in multiple sclerosis: A multinational study
10.1212/wnl.0000000000007190 · 2019 · External reference
Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients
10.1016/j.msard.2020.101930 · 2020 · External reference
Ethnic disparities in the epidemiological and clinical characteristics of multiple sclerosis
10.1016/j.msard.2023.105153 · 2024 · External reference
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: a retrospective observational cohort study
10.1016/j.lanepe.2022.100542 · 2023 · External reference
Low socioeconomic status was associated with a higher mortality risk in multiple sclerosis
10.1177/13524585221129963 · 2023 · External reference
10.1016/j.msard.2021.103474
10.1016/j.msard.2021.103474 · External reference
10.1177/13524585231221411
10.1177/13524585231221411 · External reference
Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry
10.1177/13524585211039753 · 2022 · External reference
10.1212/01.wnl.0000333252.78173.5f
10.1212/01.wnl.0000333252.78173.5f · External reference
10.1016/j.jns.2010.02.007
10.1016/j.jns.2010.02.007 · External reference
10.1177/2055217318814562
10.1177/2055217318814562 · External reference
Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients
10.1038/s41598-023-28864-x · 2023 · External reference
10.1016/j.msard.2021.103361
10.1016/j.msard.2021.103361 · External reference
10.20344/amp.11187
10.20344/amp.11187 · External reference
Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality
10.1212/wnl.0000000000004508 · 2017 · External reference
Assessment of delayed diagnosis and treatment in multiple sclerosis patients during 1990–2016
10.1007/s13760-020-01528-7 · 2021 · External reference
The relationship between ethnicity and multiple sclerosis characteristics in the United Kingdom: A UK MS Register study
10.1177/13524585241277018 · 2024 · External reference
10.1016/s1474-4422(17)30470-2
10.1016/s1474-4422(17)30470-2 · External reference
Unresolved reference
External reference
10.1080/01459740.2011.576725
10.1080/01459740.2011.576725 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1136/bmj.3.5777.725
10.1136/bmj.3.5777.725 · External reference
Unresolved reference
External reference
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
10.1007/s00415-024-12518-7 · 2024 · External reference
Unresolved reference
External reference
